Eff ect of a single asenapine treatment on Fos expression in the brain catecholamine-synthesizing neurons: impact of a chronic mild stress preconditioning

Autor: Lubica Horvathova, Zuzana Majercikova, Alexander Kiss, Jana Osacka
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Male
0301 basic medicine
Endocrinology
Diabetes and Metabolism

Catecholamines
0302 clinical medicine
Endocrinology
Pons
Conditioning
Psychological

rat
Neurons
Medulla Oblongata
Area postrema
Brain
Immunohistochemistry
chronic mild stress preconditioning
Ventral tegmental area
medicine.anatomical_structure
Locus Coeruleus
Pars reticulata
Proto-Oncogene Proteins c-fos
Antipsychotic Agents
medicine.drug
medicine.medical_specialty
Tyrosine 3-Monooxygenase
Substantia nigra
Dibenzocycloheptenes
Heterocyclic Compounds
4 or More Rings

Diseases of the endocrine glands. Clinical endocrinology
03 medical and health sciences
Internal medicine
Pars Reticulata
fos immunohistochemistry
Solitary Nucleus
medicine
Animals
Rats
Wistar

Pars Compacta
Tyrosine hydroxylase
Pars compacta
Ventral Tegmental Area
tyrosine hydroxylase immunohistochemistry
RC648-665
Rats
030104 developmental biology
Area Postrema
Microscopy
Fluorescence

nervous system
asenapine
Catecholamine
Locus coeruleus
Stress
Psychological

030217 neurology & neurosurgery
Zdroj: Endocrine Regulations, Vol 51, Iss 2, Pp 73-83 (2017)
ISSN: 1336-0329
Popis: Objective. Fos protein expression in catecholamine-synthesizing neurons of the substantia nigra (SN) pars compacta (SNC, A8), pars reticulata (SNR, A9), and pars lateralis (SNL), the ventral tegmental area (VTA, A10), the locus coeruleus (LC, A6) and subcoeruleus (sLC), the ventrolateral pons (PON-A5), the nucleus of the solitary tract (NTS-A2), the area postrema (AP), and the ventrolateral medulla (VLM-A1) was quantitatively evaluated aft er a single administration of asenapine (ASE) (designated for schizophrenia treatment) in male Wistar rats preconditioned with a chronic unpredictable variable mild stress (CMS) for 21 days. Th e aim of the present study was to reveal whether a single ASE treatment may 1) activate Fos expression in the brain areas selected; 2) activate tyrosine hydroxylase (TH)-synthesizing cells displaying Fos presence; and 3) be modulated by CMS preconditioning. Methods. Control (CON), ASE, CMS, and CMS+ASE groups were used. CMS included restraint, social isolation, crowding, swimming, and cold. Th e ASE and CMS+ASE groups received a single dose of ASE (0.3 mg/kg, s.c.) and CON and CMS saline (300 μl/rat, s.c.). The animals were sacrificed 90 min aft er the treatments. Fos protein and TH-labeled immunoreactive perikarya were analyzed on double labeled histological sections and enumerated on captured pictures using combined light and fluorescence microscope illumination. Results. Saline or CMS alone did not promote Fos expression in any of the structures investigated. ASE alone or in combination with CMS elicited Fos expression in two parts of the SN (SNC, SNR) and the VTA. Aside from some cells in the central gray tegmental nuclei adjacent to LC, where a small number of Fos profiles occurred, none or negligible Fos occurrence was detected in the other structures investigated including the LC and sLC, PON-A5, NTS-A2, AP, and VLM-A1. CMS preconditioning did not infl uence the level of Fos induction in the SN and VTA elicited by ASE administration. Similarly, the ratio between the amount of free Fos and Fos colocalized with TH was not aff ected by stress preconditioning in the SNC, SNR, and the VTA. Conclusions. Th e present study provides an anatomical/functional knowledge about the nature of the acute ASE treatment on the catecholamine-synthesizing neurons activity in certain brain structures and their missing interplay with the CMS preconditioning.
Databáze: OpenAIRE